MENU

Fox Chase Cancer Center News

Lori Giampaolo will serve as the Patient Ambassador for 2019.
September 3, 2019

Fox Chase Cancer Center Hosts 20th Annual Paws for the Cause Charity Dog Walk

PHILADELPHIA (September 3, 2019) — Fox Chase Cancer Center will hold its 20th annual Paws for the Cause, hosted by the Board of Associates, on Sunday, October 6, 2019, from 9:00 am to 12 pm.

September 3, 2019

Fox Chase Cancer Center Highlights Warning Signs and Risk Factors for Prostate Cancer

PHILADELPHIA (September 3, 2019) – September is National Prostate Cancer Awareness month. The American Cancer Society (ACS) reports that prostate cancer is the most common cancer in American men, other skin cancer.

Dietmar J. Kappes, PhD, has received a five-year, $626,072 grant from The National Institutes of Health to investigate the role of the immune gene ThPOK in breast cancer.
August 28, 2019

Fox Chase Researcher Receives Grant From NIH to Explore Role of Immune Gene in Breast Cancer

PHILADELPHIA — (August 28, 2019) Dietmar J. Kappes, PhD, has received a five-year, $626,072 grant from The National Institutes of Health to investigate the role of the immune gene ThPOK in breast cancer.

Jaye Gardiner, PhD, received a $163,500 grant from the American Cancer Society to support her research into the role of the tumor stroma in pancreatic cancer.
August 28, 2019

Fox Chase Researcher Receives American Cancer Society Grant to Study Role of Stroma in Pancreatic Cancer

PHILADELPHIA (August 28, 2019)–Jaye Gardiner, PhD, a postdoctoral researcher in the Edna Cukierman laboratory at Fox Chase Cancer Center,  received a $163,500 grant from the American Cancer Society to support her research into the role of the tumor stroma in pancreatic cancer.

Although once thought to be anomalous, the basic science driving Jaffe’s work is now realized to be pertinent to proteins whose dysfunction contributes to cancer. It has also provided a “shape-locking” approach to new therapeutics.
August 27, 2019

Structure of Human Phenylalanine Hydroxylase Provides Insight Into Possible Treatment Strategies for PKU

PHILADELPHIA (August 27, 2019) – New insights from researchers at Fox Chase Cancer Center into the structure of full-length human phenylalanine hydroxylase (PAH) may aid ongoing efforts to develop effective treatments for the metabolism disorder phenylketonuria (PKU).

Increased presence of certain immune T cells was associated with a lower risk for disease recurrence.
August 27, 2019

Activity of Immune System Could Predict Recurrence of Localized Kidney Cancer

PHILADELPHIA (August 27, 2019) – The presence or absence of certain immune cells in patients with localized kidney cancer was associated with the likelihood that the tumor would return after surgical removal, according to a new study from researchers at Fox Chase Cancer Center.

Common ipafricept treatment-emergent adverse events included fatigue, nausea, diarrhea, decreased appetite, vomiting, and taste distortions.  Overall, about 75 percent of patients responded to treatment.
August 26, 2019

Bone Toxicity of Ipafricept Outweighed Potential Efficacy for Platinum-Sensitive Ovarian Cancer

PHILADELPHIA (August 26, 2019) – Ipafricept will not be studied further for platinum-sensitive ovarian cancer after an early clinical trial revealed increased likelihood for bone toxicity at its most efficacious doses.

Compared with larynx cancer patients and across all SES geographies, tonsil cancer patients were likely to be younger and more likely to be white. These differences would be expected with tonsil cancer caused by HPV.
August 26, 2019

Tonsil Cancer Rates Increasing Throughout All Socioeconomic Levels

PHILADELPHIA (August 26, 2019) - A recent study from a researcher at Fox Chase Cancer Center found that incidence rates of tonsil cancer in the United States are increasing in both high and low socioeconomic groups. This trend has been attributed to increasing chronic oral infections with HPV.

Pages

Connect with Fox Chase